Walgreens agreed to pay the United States $300M, plus interest at a rate of 4.00% per annum accruing from October 20, 2024, of which $150M shall constitute restitution, to resolve False Claims Act ...

Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy ...

Walgreens has agreed to pay $300 million to settle U.S. prosecutors' allegations that it illegally filled millions of invalid ...

Despite a solid Q4 2024 performance, Genuine Parts' 2025 outlook is cautious with expected EPS between $6.95 - $7.45, ...

Arrowhead Pharmaceuticals, Inc. today announced that, effective May 13, 2025, Arrowhead's Chief Financial Officer, Ken Myszkowski, will retire after 16 years of service to the company and will be ...

Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing ...